Up to 80% of trials fail to meet their enrollment objectives. When a leading HPV vaccine pharmaceutical company was struggling to enroll participants in a study, our data science specialists used the IntElligo Research Stack™ platform to quickly identify qualified patients – and helped the study successfully meet its enrollment goals.